Financhill
Back

WTB Financial A Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
37

WTBFA
WTB Financial A

Last Price:
500.00
Seasonality Move:
29.73%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
135.84
Seasonality Move:
14.88%
Sell
37
WTB Financial A (WTBFA) is a Sell

Is WTB Financial A a Buy, Sell or Hold?

  • The current WTB Financial A [WTBFA] share price is $500.00. The Score for WTBFA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • WTBFA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

WTBFA Stock Price Chart

What is WTB Financial A's stock price today?

  • The WTB Financial A share price today is $500.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WTBFA is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

WTBFA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.03 Buy
Relative Strength Index (14 RSI): 55.54 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (495.02 - 501.78) Buy
Bollinger Bands (100): (465.4 - 529.88) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

WTBFA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 500 Sell
20-day SMA: 499.5 Buy
50-day SMA: 492.08 Buy
200-day SMA: 509.08 Sell
8-day EMA: 499.95 Buy
20-day EMA: 499.18 Buy
50-day EMA: 498.08 Buy
200-day EMA: 528.21 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

WTB Financial A Earnings Growth & WTBFA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

WTB Financial A Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):